The evaluation of drug safety in clinical trials is a critical element of the drug development process, ensuring that therapeutic benefits outweigh potential harms. Clinical trials, particularly in ...
As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and reshape the U.S' healthcare infrastructure, the U.S. drug regulator has unveiled ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
The US Food and Drug Administration receives about 5,000 reports each year about health problems related to the use of cosmetic products, and under a new law, the agency has issued updated ...
The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system. In an effort to modernize and provide transparency on ...
MedPage Today on MSN
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show
C HICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results